Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: Efficacy and complications of the therapy in long-term follow-up

Journal of Cardiovascular Electrophysiology

Volumn 21, Issue 8, 2010, Pages 883-889

  Syska, PaweŁ ^a   Przybylski, Andrzej ^a   Chojnowska, Lidia ^a   Lewandowski, MichaŁ ^a   SterliŃski, MacIej ^a   Maciag, Aleksander ^a   Gepner, Katarzyna ^a   Pytkowski, Mariusz ^a   Kowalik, Ilona ^a   Mczyńska Mazuruk, Renata ^a   RuzyŁŁo, Witold ^a   Szwed, Hanna ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

atrial fibrillation; hypertrophic cardiomyopathy; implantable defibrillator; sudden death

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; VERAPAMIL;

ADULT; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CLINICAL TRIAL; DEFIBRILLATOR; DEVICE INFECTION; FATALITY; FEMALE; FOLLOW UP; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANT; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; SECONDARY PREVENTION; SUDDEN DEATH; THERAPY EFFECT; TREATMENT OUTCOME;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; DISEASE-FREE SURVIVAL; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POLAND; PROPORTIONAL HAZARDS MODELS; PROSTHESIS FAILURE; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TACHYCARDIA, VENTRICULAR; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77955239563     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2009.01716.x     Document Type: Article

References (34)

1. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE : Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary artery risk development in (young) adults. Circulation 1995 92 : 785 789.
2. Teare D : Asymmetrical hypertrophy of the heart in young adults. Br Heart J 1958 20 : 1 18.
3. Maron BJ : Hypertrophic cardiomyopathy: A systematic review. JAMA 2002 287 : 1308 1320.
4. Spirito P, Seidman CE, McKenna WJ, Maron BJ : The management of hypertrophic cardiomyopathy. N Engl J Med 1997 336 : 775 785.
5. Maron BJ : Sudden death in young athletes. N Engl J Med 2003 349 : 1064 1075.
6. Maron BJ, Shen W-K, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NAM III., Casey SA, Stanton MS, Betocchi S, Spirito P : Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000 342 : 365 373.
7. Begley DA, Mohiddin SA, Tripodi D, Winkler JB, Fananapazir L : Efficacy of implantable cardioverter-defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 2003 26 : 1887 1896.
8. Przybylski A, Małecka L, Pytkowski M, Chojnowska L, Lewandowski M, Sterliński M, Maciag A, Rużyłło W, Szwed H : Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy - dillemas and difficulties. Kardiol Pol 2005 63 : 391 397.
9. Marin F, Gimeno JR, Payá E, Garcia-Alberola A, Péceresrez-Alvarez L, Fernández X, de la Morena G, Sogorb F, Castro-Beiras A, Valdéceress M, Martinez JG, Monserrat L : Implantable-cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centres. Rev Esp Cardiol 2006 59 : 537 544.
10. Almquist AK, Montgomery JV, Haas TS, Maron BJ : Cardioverter- defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy. Heart Rhythm 2005 2 : 814 819.
11. Maron BJ, Spirito P, Shen W-K, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NAM III., Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P : Outcomes of patients with implantable cardioverter-defibrillators for prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 2007 298 : 405 412.
12. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg MJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C : ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). Eur Heart J 2006 27 : 2099 2140.
13. Link MS, Hill SL, Cliff DL, Swygman CA, Estes NAM III., Berul CI : Comparison of frequency of complications of implantable-cardioverter- defibrillators in children versus adults. Am J Cardiol 1999 83 : 263 266.
14. Korte T, Köditz H, Niehaus M, Paul T, Tebbenjohanns J : High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter-defibrillator. Pacing Clin Electrophysiol 2004 27 : 924 932.
15. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH III., Spirito P, Ten Cate FJ, Wigle ED : American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 2003 24 : 1965 1991. (Pubitemid 37336422)
16. McKenna WJ, Behr ER : Hypertrophic cardiomyopathy: Management, risk stratification, and prevention of sudden death. Heart 2002 87 : 169 176.
17. Maron BJ, Spirito P : Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol 2008 19 : 1118 1126.
18. Kofflard MJM, Ten Cate FJ, Van Der Lee C, van Domburg RT : Hypertrophic cardiomyopathy in a large community-based population: Clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. J Am Coll Cardiol 2003 41 : 987 993.
19. Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, Mahon NG, McKenna WJ : Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients. J Am Coll Cardiol 2000 36 : 2212 2218.
20. Frenneaux MP : Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy. Heart 2004 90 : 570 575.
21. Woo A, Monakier D, Harris L, Hill A, Shah P, Wigle ED, Rakowski H, Rozenblyum E, Cameron DA : Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathy. Heart 2007 93 : 1044 1045.
22. Elliott PM, Sharma S, Varnava A, Poloniecki J, Rowland E, McKenna WJ : Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1999 33 : 1596 1601.
23. Maron BJ, Savage DD, Wolfson JK, Epstein SE : Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective study. Am J Cardiol 1981 48 : 252 257.
24. McKenna WJ, Franklin RC, Nihoyannopoulos P, Robinson KC, Deanfield JE : Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy. J Am Cardiol 1988 11 : 147 153.
25. Monserrat L, Elliott PM, Gimeno JR, Sharma S, Penas-Lado M, McKenna WJ : Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: An independent marker of sudden death risk in young patients. J Am Coll Cardiol 2003 42 : 873 879.
26. Elliott PM, Gimeno JR, Mahon NG, Poloniecki J, McKenna WJ : Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 2001 357 : 420 424.
27. Olivotto I, Gistri R, Petrone P, Pedemonte E, Vargiu D, Cecchi F : Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2003 41 : 315 321.
28. Spirito P, Maron BJ : Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Cardiol 1990 15 : 1521 1526. (Pubitemid 20174311)
29. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ : Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000 342 : 1778 1785.
30. Maron BJ, Haas TS : Unanticipated long-term survival after cardiac arrest in hypertrophic cardiomyopathy. Circulation 2007 116 (Suppl.II II 766.
31. Lin G, Nishimura RA, Gersh BJ, Phil D, Ommen SR, Ackerman MJ, Brady PA : Device complications and inappropriate implantable cardioverter-defibrillator shocks in patients with hypertrophic cardiomyopathy. Heart 2009 95 : 709 714.
32. Deisenhofer I, Kolb C, Ndrepepa G, Schreieck J, Karch M, Schmieder S, Zrenner B, Schmitt C : Do current dual chamber cardioverter-defibrillators have advantages over conventional single-chamber cardioverter-defibrillators in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol 2001 12 : 134 142.
33. Hauser RG, Maron BJ, Marine JE, Lampert R, Kadish AH, Winters SL, Scher DL, Biria M, Kalia A : Safety and efficacy of transvenous high-voltage implantable cardioverter-defibrillator leads in high-risk hypertrophic cardiomyopathy patients. Heart Rhythm 2008 5 : 1517 1522.
34. Wilkoff BL, Love CJ, Byrd CL, Bongiorni MG, Carrillo RG, Crossley GH III., Epstein LM, Friedman RA, Kennergren CE, Mitkowski P, Schaerf RH, Wazni OM : Transvenous Lead Extraction: Heart Rhythm Society Expert Consensus on Facilities, Training, Indications, and Patient Management: This document was endorsed by the American Heart Association (AHA), 25 May 2009. Heart Rhythm 2009 6 : 1085 1104.